RhumbLine Advisers’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $224K | Buy |
+9,956
| New | +$224K | ﹤0.01% | 3166 |
|
|
2024
Q1 | – | Sell |
-23
| Closed | -$339 | – | 4268 |
|
|
2023
Q4 | $339 | Hold |
23
| – | – | ﹤0.01% | 4216 |
|
|
2023
Q3 | $556 | Hold |
23
| – | – | ﹤0.01% | 4225 |
|
|
2023
Q2 | $309 | Buy |
+23
| New | +$309 | ﹤0.01% | 4338 |
|
|
2021
Q2 | – | Sell |
-786
| Closed | -$162K | – | 3121 |
|
|
2021
Q1 | $162K | Buy |
786
+1
| +0.1% | +$206 | ﹤0.01% | 2874 |
|
|
2020
Q4 | $157K | Buy |
785
+49
| +7% | +$9.8K | ﹤0.01% | 2898 |
|
|
2020
Q3 | $122K | Sell |
736
-108
| -13% | -$17.9K | ﹤0.01% | 2834 |
|
|
2020
Q2 | $209K | Buy |
844
+54
| +7% | +$13.4K | ﹤0.01% | 2748 |
|
|
2020
Q1 | $144K | Hold |
790
| – | – | ﹤0.01% | 2690 |
|
|
2019
Q4 | $229K | Buy |
790
+4
| +0.5% | +$1.16K | ﹤0.01% | 2704 |
|
|
2019
Q3 | $214K | Sell |
786
-6
| -0.8% | -$1.63K | ﹤0.01% | 2729 |
|
|
2019
Q2 | $298K | Sell |
792
-32
| -4% | -$12K | ﹤0.01% | 2609 |
|
|
2019
Q1 | $221K | Sell |
824
-11
| -1% | -$2.95K | ﹤0.01% | 2708 |
|
|
2018
Q4 | $178K | Buy |
835
+284
| +52% | +$60.5K | ﹤0.01% | 2765 |
|
|
2018
Q3 | $247K | Sell |
551
-42
| -7% | -$18.8K | ﹤0.01% | 2619 |
|
|
2018
Q2 | $241K | Buy |
593
+180
| +44% | +$73.2K | ﹤0.01% | 2647 |
|
|
2018
Q1 | $226K | Buy |
413
+33
| +9% | +$18.1K | ﹤0.01% | 2556 |
|
|
2017
Q4 | $230K | Sell |
380
-88
| -19% | -$53.3K | ﹤0.01% | 2576 |
|
|
2017
Q3 | $216K | Buy |
468
+14
| +3% | +$6.46K | ﹤0.01% | 2693 |
|
|
2017
Q2 | $184K | Buy |
+454
| New | +$184K | ﹤0.01% | 2787 |
|